Andrew Hykes - Oct 20, 2022 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
Chief Operating Officer
Signature
/s/ Angela Ahmad, attorney-in-fact for Andrew Hykes
Stock symbol
NARI
Transactions as of
Oct 20, 2022
Transactions value $
-$651,007
Form type
4
Date filed
10/24/2022, 05:20 PM
Previous filing
Oct 4, 2022
Next filing
Nov 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Sale -$110K -1.54K -1.19% $71.45 128K Oct 20, 2022 Direct F1, F2
transaction NARI Common Stock Sale -$324K -4.49K -3.5% $72.04 124K Oct 20, 2022 Direct F1, F3
transaction NARI Common Stock Sale -$188K -2.57K -2.07% $73.14 121K Oct 20, 2022 Direct F1, F4
transaction NARI Common Stock Sale -$29.6K -400 -0.33% $73.88 121K Oct 20, 2022 Direct F1, F5
holding NARI Common Stock 1.55K Oct 20, 2022 By Child 1
holding NARI Common Stock 1.55K Oct 20, 2022 By Child 2
holding NARI Common Stock 1.55K Oct 20, 2022 By Child 3
holding NARI Common Stock 1K Oct 20, 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
F2 This transaction was executed in multiple trades at prices ranging from $70.74 to $71.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $71.75 to $72.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $72.75 to $73.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $73.79 to $74.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.